Joel is a Member in the firm's Corporate & Securities Section, a member of the firm's Opinions Committee, and a former member of the Policy Committee. Joel concentrates his practice on corporate, commercial, and securities matters, as well as strategic transactions and corporate structuring and restructuring.
With extensive experience counseling high-technology businesses and the individuals creating them, Joel frequently guides acquisitions, collaborations, and licensing transactions in the life sciences industry. As more life sciences companies have extended their activities from discovery to development, his practice has been more involved with development and later stage activity.
Joel has also functioned as counsel for several publicly and privately held companies in various industries, including media, software, packaged and consumer goods, apparel, financial, packaging, and real estate. In addition to guiding numerous domestic mergers, acquisitions, dispositions, and public offerings to successful conclusions, he has served as US counsel to several overseas firms in connection with establishing operations, their conduct of public offerings, and their acquisitions in the United States.
In the mergers and acquisitions area, Joel has led the acquisitions of public and private companies in media, marketing, apparel, life sciences, medical device, and other industries, and has represented numerous public and private sellers of entire enterprises, divisions, or subsidiaries. He has also been involved in acquiring businesses in Chapter 11 proceedings and has directed several corporate reorganizations.
He has served as counsel to many boards of directors and special committees, and advised investment bankers on a myriad of matters, including representing them in their roles as financial advisors, and managing underwriters.
Honors and Recognitions
· Named to the New York Super Lawyers list (2006-2011)
· Named to The Best Lawyers in America for Corporate Law (2005-2012)
· Named one of "New York Area's Best Lawyers" in New York Magazine (2011)
· AV rated by Martindale-Hubbell
Professional and Community Affiliations
· Former Chairman of the Corporation Law Committee of the Association of the Bar of the City of New York
· Member of the Securities Law Committee of the New York State Bar Association
· Member of the TriBar Opinion Committee
· Member of the Negotiated Acquisitions Committee of the American Bar Association
· Member of the Board of Directors and Executive Committee of the New York Biotechnology Association (NYBA)
Recent Speaking Engagements
Joel is a frequent lecturer on topics such as underwriting public offerings of securities, corporate compliance, financings, acquiring and selling firms, fairness opinions, biotech-to-biotech acquisitions and dispositions, private placements, and legal opinion matters.
· Panelist, "Preparing For The Sale Of A Company," New York Biotechnology Association (NYBA) 21st Annual Meeting (May 2012)
· Panelist, " From the Kickoff to the Closing: Taking the Steps to Sell or Go Public with Your Company," New York Biotechnology Association (NYBA) 20th Annual Meeting (April 2011)
· Panelist, "Biotech M&A - How to Sell Your Company in an Environment of Consolidation," BIO International Convention (June 2009)
Joel is admitted to practice in New York. He received his B.A. from Yale University and earned his J.D., cum laude, from Columbia Law School.
Industries
Education
Financial Services
Health Care
Internet & e-Commerce
Life Sciences
Manufacturing
Professional Services
Retail & Consumer Products
Shipping & Logistics